Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oceaneering International (OII) Common Equity (2016 - 2025)

Oceaneering International (OII) has disclosed Common Equity for 17 consecutive years, with $848.1 million as the latest value for Q2 2025.

  • On a quarterly basis, Common Equity rose 29.07% to $848.1 million in Q2 2025 year-over-year; TTM through Jun 2025 was $848.1 million, a 29.07% increase, with the full-year FY2024 number at $720.3 million, up 13.6% from a year prior.
  • Common Equity was $848.1 million for Q2 2025 at Oceaneering International, up from $779.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $848.1 million in Q2 2025 to a low of $476.7 million in Q2 2022.
  • A 5-year average of $597.9 million and a median of $557.1 million in 2021 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: decreased 15.28% in 2022, then increased 29.07% in 2025.
  • Oceaneering International's Common Equity stood at $505.0 million in 2021, then rose by 2.93% to $519.7 million in 2022, then grew by 22.0% to $634.1 million in 2023, then increased by 13.6% to $720.3 million in 2024, then rose by 17.74% to $848.1 million in 2025.
  • Per Business Quant, the three most recent readings for OII's Common Equity are $848.1 million (Q2 2025), $779.1 million (Q1 2025), and $720.3 million (Q4 2024).